Ligand profile
ZINC6729875
Virtual-screening candidate from ZINC.
Bound to: KP13_03018 — Imidazolonepropionase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC6729875- UniProt (similar protein)
Q81WF0- Tanimoto
- 0.971
- Target protein
- KP13_03018
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 57.7
- −1 ≤ LogP ≤ 5 2.10
- MW ≤ 500 Da 310.4
- LogP ≤ 5 2.10
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 57.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCS(=O)(=O)N(C)c1ccc(C(=O)N2CCCCC2)cc1CCS(=O)(=O)N(C)c1ccc(C(=O)N2CCCCC2)cc1
InChI=1S/C15H22N2O3S/c1-3-21(19,20)16(2)14-9-7-13(8-10-14)15(18)17-11-5-4-6-12-17/h7-10H,3-6,11-12H2,1-2H3InChI=1S/C15H22N2O3S/c1-3-21(19,20)16(2)14-9-7-13(8-10-14)15(18)17-11-5-4-6-12-17/h7-10H,3-6,11-12H2,1-2H3
IAPJAFPQZIDHSX-UHFFFAOYSA-NIAPJAFPQZIDHSX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL4532317
- Homolog
- Q81WF0
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC6729875 →
- ZINC ZINC20 ZINC6729875 →
- UniProt UniProt Q81WF0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC6729875”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03018.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).